 | • レポートコード：QYR2104Z4670 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肺炎診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（連鎖球菌ベース、レジオネラベース、クラミドフィラベース、ウイルス性肺炎ベース、マイコプラズマ肺炎ベース）、用途別市場規模（病院、診療所、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肺炎診断の市場動向 ・企業の競争状況、市場シェア ・肺炎診断の種類別市場規模（連鎖球菌ベース、レジオネラベース、クラミドフィラベース、ウイルス性肺炎ベース、マイコプラズマ肺炎ベース） ・肺炎診断の用途別市場規模（病院、診療所、診断センター、その他） ・肺炎診断の北米市場規模2016-2027（アメリカ、カナダ） ・肺炎診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肺炎診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肺炎診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・肺炎診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Glaxo Smith Kline、Affymetrix、Becton Dickinson、BioMerieux、Cepheid、Diamedix/Erba） ・結論 |
Market Analysis and Insights: Global Pneumonia Diagnostic Market
The global Pneumonia Diagnostic market size is projected to reach US$ 636.1 million by 2026, from US$ 446.3 million in 2019, at a CAGR of 5.1% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pneumonia Diagnostic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pneumonia Diagnostic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pneumonia Diagnostic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pneumonia Diagnostic market.
Global Pneumonia Diagnostic Scope and Market Size
Pneumonia Diagnostic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Segment by Application
Hospitals
Clinics
Diagnostic Centres
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
Glaxo Smith Kline
Affymetrix
Becton Dickinson
BioMerieux
Cepheid
Diamedix/Erba
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Streptococcus-based
1.2.3 Legionella-based
1.2.4 Chlamydophila-based
1.2.5 Viral Pneumonia-based
1.2.6 Mycoplasma Pneumonia-based
1.3 Market by Application
1.3.1 Global Pneumonia Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Centres
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pneumonia Diagnostic Market Perspective (2016-2027)
2.2 Pneumonia Diagnostic Growth Trends by Regions
2.2.1 Pneumonia Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pneumonia Diagnostic Historic Market Share by Regions (2016-2021)
2.2.3 Pneumonia Diagnostic Forecasted Market Size by Regions (2022-2027)
2.3 Pneumonia Diagnostic Industry Dynamic
2.3.1 Pneumonia Diagnostic Market Trends
2.3.2 Pneumonia Diagnostic Market Drivers
2.3.3 Pneumonia Diagnostic Market Challenges
2.3.4 Pneumonia Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pneumonia Diagnostic Players by Revenue
3.1.1 Global Top Pneumonia Diagnostic Players by Revenue (2016-2021)
3.1.2 Global Pneumonia Diagnostic Revenue Market Share by Players (2016-2021)
3.2 Global Pneumonia Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pneumonia Diagnostic Revenue
3.4 Global Pneumonia Diagnostic Market Concentration Ratio
3.4.1 Global Pneumonia Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Diagnostic Revenue in 2020
3.5 Pneumonia Diagnostic Key Players Head office and Area Served
3.6 Key Players Pneumonia Diagnostic Product Solution and Service
3.7 Date of Enter into Pneumonia Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pneumonia Diagnostic Breakdown Data by Type
4.1 Global Pneumonia Diagnostic Historic Market Size by Type (2016-2021)
4.2 Global Pneumonia Diagnostic Forecasted Market Size by Type (2022-2027)
5 Pneumonia Diagnostic Breakdown Data by Application
5.1 Global Pneumonia Diagnostic Historic Market Size by Application (2016-2021)
5.2 Global Pneumonia Diagnostic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pneumonia Diagnostic Market Size (2016-2027)
6.2 North America Pneumonia Diagnostic Market Size by Type
6.2.1 North America Pneumonia Diagnostic Market Size by Type (2016-2021)
6.2.2 North America Pneumonia Diagnostic Market Size by Type (2022-2027)
6.2.3 North America Pneumonia Diagnostic Market Size by Type (2016-2027)
6.3 North America Pneumonia Diagnostic Market Size by Application
6.3.1 North America Pneumonia Diagnostic Market Size by Application (2016-2021)
6.3.2 North America Pneumonia Diagnostic Market Size by Application (2022-2027)
6.3.3 North America Pneumonia Diagnostic Market Size by Application (2016-2027)
6.4 North America Pneumonia Diagnostic Market Size by Country
6.4.1 North America Pneumonia Diagnostic Market Size by Country (2016-2021)
6.4.2 North America Pneumonia Diagnostic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Pneumonia Diagnostic Market Size (2016-2027)
7.2 Europe Pneumonia Diagnostic Market Size by Type
7.2.1 Europe Pneumonia Diagnostic Market Size by Type (2016-2021)
7.2.2 Europe Pneumonia Diagnostic Market Size by Type (2022-2027)
7.2.3 Europe Pneumonia Diagnostic Market Size by Type (2016-2027)
7.3 Europe Pneumonia Diagnostic Market Size by Application
7.3.1 Europe Pneumonia Diagnostic Market Size by Application (2016-2021)
7.3.2 Europe Pneumonia Diagnostic Market Size by Application (2022-2027)
7.3.3 Europe Pneumonia Diagnostic Market Size by Application (2016-2027)
7.4 Europe Pneumonia Diagnostic Market Size by Country
7.4.1 Europe Pneumonia Diagnostic Market Size by Country (2016-2021)
7.4.2 Europe Pneumonia Diagnostic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pneumonia Diagnostic Market Size (2016-2027)
8.2 Asia-Pacific Pneumonia Diagnostic Market Size by Type
8.2.1 Asia-Pacific Pneumonia Diagnostic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pneumonia Diagnostic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pneumonia Diagnostic Market Size by Type (2016-2027)
8.3 Asia-Pacific Pneumonia Diagnostic Market Size by Application
8.3.1 Asia-Pacific Pneumonia Diagnostic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pneumonia Diagnostic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pneumonia Diagnostic Market Size by Application (2016-2027)
8.4 Asia-Pacific Pneumonia Diagnostic Market Size by Region
8.4.1 Asia-Pacific Pneumonia Diagnostic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pneumonia Diagnostic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pneumonia Diagnostic Market Size (2016-2027)
9.2 Latin America Pneumonia Diagnostic Market Size by Type
9.2.1 Latin America Pneumonia Diagnostic Market Size by Type (2016-2021)
9.2.2 Latin America Pneumonia Diagnostic Market Size by Type (2022-2027)
9.2.3 Latin America Pneumonia Diagnostic Market Size by Type (2016-2027)
9.3 Latin America Pneumonia Diagnostic Market Size by Application
9.3.1 Latin America Pneumonia Diagnostic Market Size by Application (2016-2021)
9.3.2 Latin America Pneumonia Diagnostic Market Size by Application (2022-2027)
9.3.3 Latin America Pneumonia Diagnostic Market Size by Application (2016-2027)
9.4 Latin America Pneumonia Diagnostic Market Size by Country
9.4.1 Latin America Pneumonia Diagnostic Market Size by Country (2016-2021)
9.4.2 Latin America Pneumonia Diagnostic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pneumonia Diagnostic Market Size (2016-2027)
10.2 Middle East & Africa Pneumonia Diagnostic Market Size by Type
10.2.1 Middle East & Africa Pneumonia Diagnostic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pneumonia Diagnostic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pneumonia Diagnostic Market Size by Type (2016-2027)
10.3 Middle East & Africa Pneumonia Diagnostic Market Size by Application
10.3.1 Middle East & Africa Pneumonia Diagnostic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pneumonia Diagnostic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pneumonia Diagnostic Market Size by Application (2016-2027)
10.4 Middle East & Africa Pneumonia Diagnostic Market Size by Country
10.4.1 Middle East & Africa Pneumonia Diagnostic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pneumonia Diagnostic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Pneumonia Diagnostic Introduction
11.1.4 Abbott Revenue in Pneumonia Diagnostic Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Glaxo Smith Kline
11.2.1 Glaxo Smith Kline Company Details
11.2.2 Glaxo Smith Kline Business Overview
11.2.3 Glaxo Smith Kline Pneumonia Diagnostic Introduction
11.2.4 Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2016-2021)
11.2.5 Glaxo Smith Kline Recent Development
11.3 Affymetrix
11.3.1 Affymetrix Company Details
11.3.2 Affymetrix Business Overview
11.3.3 Affymetrix Pneumonia Diagnostic Introduction
11.3.4 Affymetrix Revenue in Pneumonia Diagnostic Business (2016-2021)
11.3.5 Affymetrix Recent Development
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Pneumonia Diagnostic Introduction
11.4.4 Becton Dickinson Revenue in Pneumonia Diagnostic Business (2016-2021)
11.4.5 Becton Dickinson Recent Development
11.5 BioMerieux
11.5.1 BioMerieux Company Details
11.5.2 BioMerieux Business Overview
11.5.3 BioMerieux Pneumonia Diagnostic Introduction
11.5.4 BioMerieux Revenue in Pneumonia Diagnostic Business (2016-2021)
11.5.5 BioMerieux Recent Development
11.6 Cepheid
11.6.1 Cepheid Company Details
11.6.2 Cepheid Business Overview
11.6.3 Cepheid Pneumonia Diagnostic Introduction
11.6.4 Cepheid Revenue in Pneumonia Diagnostic Business (2016-2021)
11.6.5 Cepheid Recent Development
11.7 Diamedix/Erba
11.7.1 Diamedix/Erba Company Details
11.7.2 Diamedix/Erba Business Overview
11.7.3 Diamedix/Erba Pneumonia Diagnostic Introduction
11.7.4 Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2016-2021)
11.7.5 Diamedix/Erba Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pneumonia Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Streptococcus-based
Table 3. Key Players of Legionella-based
Table 4. Key Players of Chlamydophila-based
Table 5. Key Players of Viral Pneumonia-based
Table 6. Key Players of Mycoplasma Pneumonia-based
Table 7. Global Pneumonia Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pneumonia Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pneumonia Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pneumonia Diagnostic Market Share by Regions (2016-2021)
Table 11. Global Pneumonia Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pneumonia Diagnostic Market Share by Regions (2022-2027)
Table 13. Pneumonia Diagnostic Market Trends
Table 14. Pneumonia Diagnostic Market Drivers
Table 15. Pneumonia Diagnostic Market Challenges
Table 16. Pneumonia Diagnostic Market Restraints
Table 17. Global Pneumonia Diagnostic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pneumonia Diagnostic Market Share by Players (2016-2021)
Table 19. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Diagnostic as of 2020)
Table 20. Ranking of Global Top Pneumonia Diagnostic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pneumonia Diagnostic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pneumonia Diagnostic Product Solution and Service
Table 24. Date of Enter into Pneumonia Diagnostic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pneumonia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pneumonia Diagnostic Revenue Market Share by Type (2016-2021)
Table 28. Global Pneumonia Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pneumonia Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pneumonia Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pneumonia Diagnostic Revenue Market Share by Application (2016-2021)
Table 32. Global Pneumonia Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pneumonia Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pneumonia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pneumonia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pneumonia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pneumonia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pneumonia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pneumonia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pneumonia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pneumonia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pneumonia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pneumonia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pneumonia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pneumonia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pneumonia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pneumonia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pneumonia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pneumonia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pneumonia Diagnostic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pneumonia Diagnostic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pneumonia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pneumonia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pneumonia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pneumonia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pneumonia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pneumonia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pneumonia Diagnostic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pneumonia Diagnostic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pneumonia Diagnostic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pneumonia Diagnostic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pneumonia Diagnostic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pneumonia Diagnostic Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Pneumonia Diagnostic Product
Table 67. Abbott Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. Glaxo Smith Kline Company Details
Table 70. Glaxo Smith Kline Business Overview
Table 71. Glaxo Smith Kline Pneumonia Diagnostic Product
Table 72. Glaxo Smith Kline Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 73. Glaxo Smith Kline Recent Development
Table 74. Affymetrix Company Details
Table 75. Affymetrix Business Overview
Table 76. Affymetrix Pneumonia Diagnostic Product
Table 77. Affymetrix Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 78. Affymetrix Recent Development
Table 79. Becton Dickinson Company Details
Table 80. Becton Dickinson Business Overview
Table 81. Becton Dickinson Pneumonia Diagnostic Product
Table 82. Becton Dickinson Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 83. Becton Dickinson Recent Development
Table 84. BioMerieux Company Details
Table 85. BioMerieux Business Overview
Table 86. BioMerieux Pneumonia Diagnostic Product
Table 87. BioMerieux Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 88. BioMerieux Recent Development
Table 89. Cepheid Company Details
Table 90. Cepheid Business Overview
Table 91. Cepheid Pneumonia Diagnostic Product
Table 92. Cepheid Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 93. Cepheid Recent Development
Table 94. Diamedix/Erba Company Details
Table 95. Diamedix/Erba Business Overview
Table 96. Diamedix/Erba Pneumonia Diagnostic Product
Table 97. Diamedix/Erba Revenue in Pneumonia Diagnostic Business (2016-2021) & (US$ Million)
Table 98. Diamedix/Erba Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pneumonia Diagnostic Market Share by Type: 2020 VS 2027
Figure 2. Streptococcus-based Features
Figure 3. Legionella-based Features
Figure 4. Chlamydophila-based Features
Figure 5. Viral Pneumonia-based Features
Figure 6. Mycoplasma Pneumonia-based Features
Figure 7. Global Pneumonia Diagnostic Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Diagnostic Centres Case Studies
Figure 11. Other Case Studies
Figure 12. Pneumonia Diagnostic Report Years Considered
Figure 13. Global Pneumonia Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Pneumonia Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pneumonia Diagnostic Market Share by Regions: 2020 VS 2027
Figure 16. Global Pneumonia Diagnostic Market Share by Regions (2022-2027)
Figure 17. Global Pneumonia Diagnostic Market Share by Players in 2020
Figure 18. Global Top Pneumonia Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumonia Diagnostic as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Pneumonia Diagnostic Revenue in 2020
Figure 20. Global Pneumonia Diagnostic Revenue Market Share by Type (2016-2021)
Figure 21. Global Pneumonia Diagnostic Revenue Market Share by Type (2022-2027)
Figure 22. North America Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Pneumonia Diagnostic Market Share by Type (2016-2027)
Figure 24. North America Pneumonia Diagnostic Market Share by Application (2016-2027)
Figure 25. North America Pneumonia Diagnostic Market Share by Country (2016-2027)
Figure 26. United States Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Pneumonia Diagnostic Market Share by Type (2016-2027)
Figure 30. Europe Pneumonia Diagnostic Market Share by Application (2016-2027)
Figure 31. Europe Pneumonia Diagnostic Market Share by Country (2016-2027)
Figure 32. Germany Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Pneumonia Diagnostic Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Pneumonia Diagnostic Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Pneumonia Diagnostic Market Share by Region (2016-2027)
Figure 42. China Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Pneumonia Diagnostic Market Share by Type (2016-2027)
Figure 50. Latin America Pneumonia Diagnostic Market Share by Application (2016-2027)
Figure 51. Latin America Pneumonia Diagnostic Market Share by Country (2016-2027)
Figure 52. Mexico Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Pneumonia Diagnostic Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Pneumonia Diagnostic Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Pneumonia Diagnostic Market Share by Country (2016-2027)
Figure 58. Turkey Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Pneumonia Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Abbott Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 62. Glaxo Smith Kline Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 63. Affymetrix Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 64. Becton Dickinson Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 65. BioMerieux Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 66. Cepheid Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 67. Diamedix/Erba Revenue Growth Rate in Pneumonia Diagnostic Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の肺炎市場規模・現状・予測（2021年-2027年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…- 世界の人工呼吸器関連肺炎（VAP）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Ventilator Associated Pneumonia (VAP) Market The global Ventilator Associated Pneumonia (VAP) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and…
- 世界の院内肺炎予防市場規模・現状・予測（2021年-2027年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
- 世界の肺炎治療薬市場規模・現状・予測（2021年-2027年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…
- 世界の市中肺炎（CAP）市場規模・現状・予測（2021年-2027年） Community-acquired pneumonia (CAP) refers to pneumonia (any of several lung diseases) contracted by a person with little contact with the healthcare system. The market of CAP treatment and diagnosis in further segmented with respect to major geographies of North America, Europe, Asia-Pacific, and La…